Table 3.
Length of rapamycin usage | Women | Men |
---|---|---|
< 1 month | 23.3% (17) | 11.9% (31) |
1–6 months | 26% (19) | 30.4% (79) |
6 months–1 year | 16.4% (12) | 19.2% (50) |
1–3 years | 23.5% (18) | 24.7% (61) |
> 3 years | 15.0% (7) | 9.6% (39) |
Length of rapamycin usage | Women | Men |
---|---|---|
< 1 month | 23.3% (17) | 11.9% (31) |
1–6 months | 26% (19) | 30.4% (79) |
6 months–1 year | 16.4% (12) | 19.2% (50) |
1–3 years | 23.5% (18) | 24.7% (61) |
> 3 years | 15.0% (7) | 9.6% (39) |